Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
University of Maryland, Baltimore
University of Maryland, Baltimore
Antalya City Hospital
Sun Yat-sen University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai JMT-Bio Inc.
University of Baghdad
Genentech, Inc.
Toros University
Marmara University
Ruijin Hospital
Peking University Cancer Hospital & Institute
Cedars-Sinai Medical Center
West China Hospital
Medical University of South Carolina
Nanfang Hospital, Southern Medical University
Hebei Medical University Fourth Hospital
Eli Lilly and Company
Necmettin Erbakan University
Peking University Cancer Hospital & Institute
Ruijin Hospital
Institut Bergonié
Institut Curie
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Xijing Hospital
Memorial Sloan Kettering Cancer Center
Hôpital du Valais
Ruijin Hospital
University of Cincinnati
Fudan University
Hebei Medical University Fourth Hospital
University of Rochester
BioLite, Inc.
National Cancer Institute (NCI)
Atlas University
Assiut University
Odense University Hospital
Dana-Farber Cancer Institute
Duke University
Xiamen University
University of California, San Francisco
Peter MacCallum Cancer Centre, Australia
Rovi Pharmaceuticals Laboratories
Fudan University
Poitiers University Hospital
Capital Medical University
University of Miami
Karolinska Institutet
University of Vic - Central University of Catalonia
Vanderbilt-Ingram Cancer Center
Cedars-Sinai Medical Center